Details for Patent: 8,715,624
✉ Email this page to a colleague
Which drugs does patent 8,715,624 protect, and when does it expire?
Patent 8,715,624 protects TOPICORT and is included in one NDA.
This patent has four patent family members in four countries.
Summary for Patent: 8,715,624
| Title: | Stable liquid desoximethasone compositions with reduced oxidized impurity |
| Abstract: | The present invention relates to a stable liquid formulation comprising desoximetasone, isopropyl myristate, a C.sub.2-C.sub.4 alcohol and a stabilizing agent. Specifically, the present invention provides a liquid formulation comprising: a) about 0.01 wt % to about 2.5 wt % desoximetasone; b) about 10 wt % to about 70 wt % isopropyl myristate; c) about 20 wt % to about 70 wt % C.sub.2-C.sub.4 alcohol; and d) a stabilizing agent selected from the group consisting of an oleaginous vehicle and a propellant, wherein the stabilizing agent is in an amount sufficient to reduce the formation of less than about 1 wt % 17-carboxy-9.alpha.-fluoro-11.beta.-hydroxy-16.alpha.-methyl-androsta-1,4- -diene-3-one under an accelerated storage condition. |
| Inventor(s): | Rao; Srinivasa (Valley Stream, NY), Dixit; Suresh (Ft. Worth, TX), Yacobi; Avraham (Englewood, NJ), Bailey; Arthur (Bethel, CT) |
| Assignee: | Taro Pharmaceuticals North America, Inc. (Grand Cayman, KY) |
| Application Number: | 13/605,622 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,715,624 |
|
Patent Claim Types: see list of patent claims | Formulation; Compound; Dosage form; Delivery; Use; Process; |
Drugs Protected by US Patent 8,715,624
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro | TOPICORT | desoximetasone | SPRAY;TOPICAL | 204141-001 | Apr 11, 2013 | AT | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | TREATMENT OF PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER | ⤷ Try a Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,715,624
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2609579 | ⤷ Try a Trial | |||
| European Patent Office | 1888026 | ⤷ Try a Trial | |||
| Israel | 187666 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
